CompletedPhase 4NCT01904864

Comparison of NovaFerrum® vs Ferrous Sulfate Treatment in Young Children With Nutritional Iron Deficiency Anemia

Studying Autosomal recessive sideroblastic anemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Texas Southwestern Medical Center
Principal Investigator
Patrick Leavey, MD
U Texas Southwestern
Intervention
elemental iron (NovaFerrum®)(drug)
Enrollment
80 target
Eligibility
All sexes
Timeline
20132015

Study locations (1)

Collaborators

Gensavis Pharmaceuticals, LLC

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01904864 on ClinicalTrials.gov

Other trials for Autosomal recessive sideroblastic anemia

Additional recruiting or active studies for the same condition.

See all trials for Autosomal recessive sideroblastic anemia

← Back to all trials